Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
82
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy

Canhua Yun1 Department of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3919-698X
ORCID Icon,
Meiling Wu1 Department of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of China
,
Juan Xiao2 Center of Evidence-Based Medicine, Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of China
,
Yong Liu1 Department of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of China
,
Wei Zhang1 Department of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of China
&
Jingjia Cao1 Department of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2621-7991
ORCID Icon
Pages 1427-1434 | Published online: 12 Feb 2021

References

  • Chinese Association of Thyroid Oncology. Chinese Expert Consensus on Diagnosis and Treatment of Papillary Thyroid Microcarcinoma. Chin J Clin Oncol. 2016;43(10):405–411. doi:10.3969/j.issn.1000-8179.2016.10.001
  • Chinese Society of Nuclear Medicine. Clinical guidelines for 131I therapy of differentiated thyroid cancer [J]. China J Nucl Med Mol Imaging. 2014;34(4):264–278.
  • Feng S, Tan J, et al. Clinical characteristics and 131I efficacy of papillary thyroid microcarcinoma and papillary thyroid non-micro carcinoma [J]. Int J Radiat Med Nucl Med. 2018;42:2. doi:10.3760/cma.j.issn.1673-4114.2018.02.003
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.002026462967
  • Domínguez JM, Nilo F, Martínez MT, et al. Papillary thyroid microcarcinoma: characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort [J]. Arch Endocrinol Metab. 2018;62(1):6–13. doi:10.20945/2359-399700000001329694628
  • Noguchi S, Yamashita H, Uchino S, et al. Papillary microcarcinoma[J]. World J Surg. 2008;32(5):747–753. doi:10.1007/s00268-007-9453-018264828
  • Hay ID. Management of Patients with Low-Risk Papillary Thyroid Carcinoma [J]. Endocr Pract. 2007;13(5):521–533. doi:10.4158/EP.13.5.52117872355
  • M B Amin, Edge S, Greene F, et al. 2017 AJCC Cancer Staging Manual [M]. 8th New York: Springer; 2017.
  • Youn Y-K, Kim H, Park W-Y, et al. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma [J]. J Cancer Re Therapeutics. 2010;6(4):452–457. doi:10.4103/0973-1482.77103
  • Roh J-L, Kim J-M, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis [J]. Ann Surg Oncol. 2008;15(9):2482–2486. doi:10.1245/s10434-008-0044-618612697
  • Long Y, Caixia A, Zhang W. Characteristics of 185 thyroid micropapillary carcinoma patients undergoing 131I treatment [J]. China J Nucl Med Mol Imaging. 2019;39:9. doi:10.3760/cma.j.issn.2095-2848.2019.09.005
  • Li H, Zhang Y-Q, Wang C, et al. Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer. Clin Endocrinol (Oxf). 2018;88(4):601–606. doi:10.1111/cen.1355129338092
  • Wang X, Song Q, Dongdong X. Effects of Timing of Initial Postoperative Radioactive Iodine Therapy on the Outcome of Patients with Differentiated Thyroid Cancer [J]. J China Med Univ. 2019;48(4):359–369. doi:10.12007/j.issn.0258-4646.2019.04.016
  • Xin L, Lin Y. Change of pre-ablative thyroid-stimulating hormone after thyroid hormone withdrawal and its response to 131I therapy in patients with low to intermediate risk differentiated thyroid cancer [J]. China J Nucl Med Mol Imaging. 2016;35(6):389–393. doi:10.3760/cma.j.issn.2095-2848.2016.05.003
  • Gonzalez C, Aulinas A, Colom C, et al. Thyroglobulin as early prognostic marker to predict remission at 18–24 months in differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2014;80(2):301–306. doi:10.1111/cen.1228223826916
  • Kim H, Kim S-J, Kim I-J, et al. Limited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancer [J]. Nucl Med Mol Imaging. 2013;47(4):268–272. doi:10.1007/s13139-013-0220-x24900123
  • Webb RC, Howard RS, Stojadinovic A, et al. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. J Clin Endocrinol Metab. 2012;97(8):2754–2763. doi:10.1210/jc.2012-153322639291
  • Liu J, Liang J, Lin Y. Relationship between preablative stimulated thyroglobulin and the excellent response in differentiated thyroid carcinoma [J]. China Oncology. 2019;29(2):125–130. doi:10.19401/j.cnki.1007-3639.2019.02.005
  • Lim YC, Choi EC, Yoon Y-H, et al. Central lymph node metastases in unilateral papillary thyroid microcarcinoma[J]. Br J Surg. 2009;96(3):253–257. doi:10.1002/bjs.648419224514
  • WHO. Guide to Cancer Early Diagnosis. ISBN: 978-92-4-151194-0. World Health Organization; 2017.
  • Du F, Hu S, Wu C, et al. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma].. Zhonghua Zhong Liu Za Zhi. 2018;40(8):610–613. doi:10.3760/cma.j.issn.0253-3766.2018.08.00930139032

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.